Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin.

Siddiqui A, Hanson I, Andersen JK.

Free Radic Res. 2012 Aug;46(8):1011-8. doi: 10.3109/10715762.2012.662277. Epub 2012 Feb 14.

PMID:
22329629
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.

deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I; Parkinson Study Group TEMPO; PRESTO Tyramine Substudy Investigators and Coordinators.

Mov Disord. 2006 Oct;21(10):1716-21.

PMID:
16856145
[PubMed - indexed for MEDLINE]
3.

A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.

Clarke A, Brewer F, Johnson ES, Mallard N, Hartig F, Taylor S, Corn TH.

J Neural Transm. 2003 Nov;110(11):1241-55.

PMID:
14628189
[PubMed - indexed for MEDLINE]
4.
5.

Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.

Riederer P, Konradi C, Schay V, Kienzl E, Birkmayer G, Danielczyk W, Sofic E, Youdim MB.

Adv Neurol. 1987;45:111-8.

PMID:
3030067
[PubMed - indexed for MEDLINE]
6.

Regulation of MAO-A and MAO-B gene expression.

Shih JC, Chen K.

Curr Med Chem. 2004 Aug;11(15):1995-2005. Review.

PMID:
15279563
[PubMed - indexed for MEDLINE]
7.

Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.

De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12684-9. Epub 2005 Aug 29.

PMID:
16129825
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition.

Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I.

J Addict Dis. 1998;17(1):23-34.

PMID:
9549600
[PubMed - indexed for MEDLINE]
9.

G/A polymorphism in intronic sequence affects the processing of MAO-B gene in patients with Parkinson disease.

Jakubauskiene E, Janaviciute V, Peciuliene I, Söderkvist P, Kanopka A.

FEBS Lett. 2012 Oct 19;586(20):3698-704. doi: 10.1016/j.febslet.2012.08.028. Epub 2012 Sep 10. Erratum in: FEBS Lett. 2013 Jan 31;587(3):302-3.

PMID:
22974659
[PubMed - indexed for MEDLINE]
Free Article
10.

Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines.

Lin RD, Hou WC, Yen KY, Lee MH.

Phytomedicine. 2003 Nov;10(8):650-6.

PMID:
14692725
[PubMed - indexed for MEDLINE]
11.

In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligand.

Nag S, Varrone A, Tóth M, Thiele A, Kettschau G, Heinrich T, Lehmann L, Halldin C.

Synapse. 2012 Apr;66(4):323-30. doi: 10.1002/syn.21514. Epub 2011 Dec 30.

PMID:
22124971
[PubMed - indexed for MEDLINE]
12.

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC, Nag S, Hermecz I, Magyar K, Halldin C.

Neurochem Int. 2011 Jan;58(1):60-8. doi: 10.1016/j.neuint.2010.10.013. Epub 2010 Nov 12.

PMID:
21075154
[PubMed - indexed for MEDLINE]
13.

MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.

Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Nicholls DG, Di Monte DA, Macarthur H, Andersen JK.

PLoS One. 2008 Feb 20;3(2):e1616. doi: 10.1371/journal.pone.0001616. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/3c37bef4-bb5e-4f1e-8551-01afc006df90.

PMID:
18286173
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.

Goren T, Adar L, Sasson N, Weiss YM.

J Clin Pharmacol. 2010 Dec;50(12):1420-8. doi: 10.1177/0091270010369674. Epub 2010 May 5.

PMID:
20445015
[PubMed - indexed for MEDLINE]
15.

Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).

Uebelhack R, Franke L, Schewe HJ.

Pharmacopsychiatry. 1998 Sep;31(5):187-92.

PMID:
9832350
[PubMed - indexed for MEDLINE]
16.

Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla.

Hou WC, Lin RD, Chen CT, Lee MH.

J Ethnopharmacol. 2005 Aug 22;100(1-2):216-20.

PMID:
15890481
[PubMed - indexed for MEDLINE]
17.
18.

Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.

Huang L, Lu C, Sun Y, Mao F, Luo Z, Su T, Jiang H, Shan W, Li X.

J Med Chem. 2012 Oct 11;55(19):8483-92. doi: 10.1021/jm300978h. Epub 2012 Oct 1.

PMID:
22978824
[PubMed - indexed for MEDLINE]
19.

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.

Clarke A, Johnson ES, Mallard N, Corn TH, Johnston A, Boyce M, Warrington S, MacMahon DG.

J Neural Transm. 2003 Nov;110(11):1257-71.

PMID:
14628190
[PubMed - indexed for MEDLINE]
20.

Modulations of brain amines and dopaminergic behavior by a novel, reversible and selective MAO-B inhibitor.

Mishra N, Sasmal D.

Brain Res. 2012 Aug 27;1470:45-51. doi: 10.1016/j.brainres.2012.06.037. Epub 2012 Jul 3.

PMID:
22765918
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk